期刊文献+

鼠白介素28重组腺病毒感染小鼠后的表达

The expression of mil-28 gene in the rat transfected with rat interleukin 28 recombinant adenovirus vector
下载PDF
导出
摘要 目的:观察鼠白介素28重组腺病毒(r-Ad-mIFN-λ2)感染小鼠后的表达。方法:将已成功构建的重组腺病毒r-Ad-mIFN-λ2感染小鼠,采用实时PCR、蛋白质印迹方法,检测小鼠骨骼肌mIFN-λ2基因和蛋白的表达,并监测小鼠的生长情况。结果:重组腺病毒Ad-mIFN-λ2在小鼠体内能够稳定表达,且不影响其正常生长。实时PCR结果显示Ad-mIFN-λ2组持续表达mIFN-λ2 mRNA,表达量高于空白组和空载体LacZ组;蛋白质印迹结果表明Ad-mIFN-λ2组出现明显mIFN-λ2蛋白的条带,空白组及LacZ组条带较淡;监测小鼠体质量表明感染r-Ad-mIFN-λ2的小鼠能够正常生长,与空白组和LacZ组之间差异无统计学意义。结论:构建的重组腺病毒Ad-mIFN-λ2在小鼠体内感染后能够稳定表达,且不影响其正常生长,为进一步研究mIFN-λ2在动物体内的生物学活性奠定了一定的基础。 Objective: To study the mil-28 expression in the rat transfected with the interleukin 28 recombinant adenovirus vector.Methods: Transfect the recombinant mil-28 adenovirus vector into the rat,detect the mil-28 gene expression with real-time PCR and Western blot.Results: The interleukin 28 recombinant adenovirus vector in the rat can express stably,and at the same time the rat can grow normally.In the muscle,the Ad-mIFN-lambda 2 group express the mIFN-lambda 2 gene at a higher level,while the blank group and the LacZ group at a lower level by the real-time PCR;Detected with the Western blot,Ad-mIFN-lambda 2 group appeared obviously about mIFN-lambda 2 protein strip,while the blank group and the LacZ group with lighter bands.Conclusion: The stable expression of the mIFN-lambda 2 gene in the rat was detected after transfected with the interleukin 28 recombinant adenovirus vector,and the rat can grow normally,which give a guidance to the vivo biological activity analysis of the mIFN-lambda 2 in the future.
出处 《江苏大学学报(医学版)》 CAS 2011年第5期375-377,381,共4页 Journal of Jiangsu University:Medicine Edition
基金 镇江市社会发展项目(SH2010036)
关键词 mIFN-λ2 感染 基因表达 IFN-λ2 transfection gene expression
  • 相关文献

参考文献11

  • 1Kotenko SV, Gallagher G, Baurin V, et al. IFN-hs medi- ate antiviral protection through a distinct class II cytokine receptor complex [ J ]. Nat Immunol, 2003,4 ( 1 ) : 69 - 77.
  • 2Sheppard P, Kindsogel W, Xu W, et al. IL-28, IL-29 and their class lI cytokine receptor IL-28R[ J]. Nat Immu- nol,2003,4( 1 ) :63 -68.
  • 3严玉兰,袁利学,刘洋,曹文雁,步雪峰,步志高,郑金旭.鼠IFN—λ2 CHO细胞系建立及生物学活性的研究[J].中华微生物学和免疫学杂志,2010,30(2):104-109. 被引量:3
  • 4Ferrantini M, Capone I, Belardelli F, et al. Inteferon-a and cancer: Mechanisms of action and new perspectives of clinical use [ J ]. Biochimie, 2007,89 ( 6/7 ) - 884 - 893.
  • 5Dumoutier L, Tounsi A, Michiels T , et al. Role of the interleukin(IL) -28 receptor tyrosine residues for antivi- ral and antiproliferative activity of IL-29/interferon- lambda 1: similarities with type I interferon signaling [ J ]. J Biol Chem, 2004,279 (31 ) :32269 - 32274.
  • 6Meager A, Visvalingam K, Dilger P, et al. Biological ac- tivity of interleukins-28 and-29: Comparison with type interferons [ J ]. Cytokine ,2005,31 (2) : 109 - 118.
  • 7Sato A, Ohtsuki M, Hata M, et al. Antitumor activity of IFN-lambda in murine tumor models [ J ]. J Immunol, 2006 ,176(12) : 7686 -7694.
  • 8Zitzmann K, Brand S, Baehs S, et a 1. Novel interferon- lambdas induce antiproliferative effects in neuroendo- crine tumor cells [ J ]. Biochem Biophys Res Commun, 2006,344(4) : 1334 - 1341.
  • 9Lasfar A, Lewis-Antes A, Smirnov SV, et al. Character- ization of the mouse IFN-lambda ligand-receptor system : IFN-lambdas exhibit antitumor activity against B16 mela- noma[J]. Cancer Res,2006, 66(8) :4468 -4477.
  • 10Brand S, Beigel F,Olszak T, et al. IL-28A and IL-29 mediate antiproliferative and antiviral signals in intesti- nal epithelial cells and murine CMV infection increases colonic IL-28A expression[ J]. Am J Physiol Gastroint- est Liver Physiol,2005, 289(5) : G960 -G968.

二级参考文献15

  • 1Kotenko SV, Gallagher G, Baurin VV, et al. IFN-lambdas mediate antiviral protection through a distinct class Ⅱ cytokine receptor complex. Nat Immunol, 2003,4( 1 ) : 69-77.
  • 2Sheppard P, Kindsvogel W, Xu W, et al. IL-28, IL-29 and their class Ⅱ cytokine receptor IL-28R. Nat lmmunol,2003,4( 1 ) : 63- 68.
  • 3Meager A, Visvalingam K, Dilger P, et al. Biological activity of interleukins-28 and-29: comparison with type Ⅰ interferons. Cytokine, 2005, 31(2) : 109-118.
  • 4Dumoutier L, Tounsi A, Michiels T, et al. Role of the interleukin (IL) -28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1 : similarities with type Ⅰ interferon signaling. J Biol Chem, 2004, 27 (9) : 32269-32274.
  • 5陈伟业.重组牛、猪和鸡β干扰素在CHO细胞中的高效稳定表达及其生物学活性研究.南京农业大学,2007.
  • 6Meager A. Assays for antiviral activity. Methods Mol Biol, 2004, 249: 121-134.
  • 7Bartlett NW, Buttigieg K, Kotenko SV, et al. Murine interferon lambdas( type Ⅲ interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model. J Gen Virol, 2005, 86 ( Pt 6 ) : 1589-1596.
  • 8Uze G, Monneron D. IL-28 and IL-29 : newcomers to the interferon family. Biochimie, 2007, 89(6-7): 729-734.
  • 9Zhou Z, Hamming O J, Ank N, et al. Type Ⅲ interferon (IFN)induces a type Ⅰ IFN-hke response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases. J Virol, 2007, 81 (14) : 7749-7758.
  • 10Teragawa H, Hondo T, Amano H, et al. Adverse effects of interferon on the cardiovascular system in patients with chronic hepatitis C. Jpn Heart J, 1996, 37(6) : 905-915.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部